quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:11:30·45d
SECFiling
Septerna Inc. logo

SEC Form 10-K filed by Septerna Inc.

SEPN· Septerna Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • SEPN
    Septerna Inc.
    Health Care

Recent analyst ratings

  • Dec 19UpdateRaymond James$38.00
  • Dec 15UpdateTruist$34.00
  • Nov 14UpdateWells Fargo-
  • Jun 23UpdateH.C. Wainwright$26.00
  • Feb 18UpdateWells Fargo$14.00
  • Nov 19UpdateAnalyst$38.00

Related

  • INSIDER6d
    SEC Form 4 filed by Bhatt Elizabeth
  • SEC10d
    Septerna Inc. filed SEC Form 8-K: Regulation FD Disclosure
  • PR10d
    Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
  • SEC44d
    SEC Form S-3ASR filed by Septerna Inc.
  • SEC45d
    SEC Form S-8 filed by Septerna Inc.
  • SEC45d
    Septerna Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR45d
    Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
  • INSIDER50d
    Chief People Officer Shaikhly Samira exercised 70,453 shares at a strike of $1.84 and sold $1,979,838 worth of shares (70,453 units at $28.10) (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022